| SpectraBase Spectrum ID |
8GjpRvCzU2K |
| Name |
1,4-Di-(2-Fluorobenzyl)-2-methylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
316.175105042 u |
| Formula |
C19H22F2N2 |
| InChI |
InChI=1S/C19H22F2N2/c1-15-12-22(13-16-6-2-4-8-18(16)20)10-11-23(15)14-17-7-3-5-9-19(17)21/h2-9,15H,10-14H2,1H3 |
| InChIKey |
GOIVPRQAGOPRFQ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
316.396 g/mol |
| Nominal Mass |
316 u |
| Quality |
983 |
| Retention Index |
2200 |
| SMILES |
C1(N(CCN(C1)CC=1C(=CC=CC1)F)CC=1C(=CC=CC1)F)C |
| SPLASH |
splash10-0a4i-2910000000-4d0ecd6901d20bed91f6 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(2-Fluorobenzyl)-2-methyl
1,4-bis(2-fluorobenzyl)-2-methylpiperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011209 |
